Acadia Healthcare CEO Osteen reports 3,765 shares

Acadia Healthcare Company, Inc. director and Chief Executive Officer Debra K. Osteen filed a Form 3 reporting her beneficial ownership in the company’s common stock.

Rhea-AI Filing Summary

Acadia Healthcare Company, Inc. director and Chief Executive Officer Debra K. Osteen filed a Form 3 reporting her beneficial ownership in the company’s common stock. She reported ownership of 3,765 shares of common stock, held directly, as of the event date of January 20, 2026. The filing does not list any derivative securities such as options or warrants.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider OSTEEN DEBRA K

Role Chief Executive Officer

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 3,765 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Acadia Healthcare (ACHC) CEO Debra K. Osteen report owning on this Form 3?

Debra K. Osteen reports beneficial ownership of 3,765 shares of Acadia Healthcare common stock, held directly.

What is the event date for Debra K. Osteen’s Acadia Healthcare (ACHC) Form 3?

The Form 3 identifies January 20, 2026 as the date of the event requiring the ownership statement.

What is Debra K. Osteen’s role at Acadia Healthcare (ACHC) in this Form 3?

She is identified as both a Director and an Officer, serving as Chief Executive Officer of Acadia Healthcare.

Are Debra K. Osteen’s Acadia Healthcare (ACHC) shares held directly or indirectly?

The Form 3 shows the 3,765 common shares as held with direct (D) ownership and no stated indirect ownership structure.

Does Debra K. Osteen report any derivative securities of Acadia Healthcare (ACHC) on this Form 3?

No derivative securities are listed; the Form 3 does not report options, warrants, or other derivative instruments.

Is Debra K. Osteen reported as a 10% owner of Acadia Healthcare (ACHC)?

No, the Form 3 indicates she is a director and Chief Executive Officer but not a 10% owner.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/21/2026 - 04:30 PM EST Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

OSTEEN DEBRA K

(Last) (First) (Middle)

4020 ASPEN GROVE DRIVE, SUITE 900

(Street)

FRANKLIN TN 37067

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/20/2026

3. Issuer Name and Ticker or Trading Symbol
Acadia Healthcare Company, Inc. [ ACHC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	3,765	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Brian Farley as Attorney in Fact for Debra K. Osteen	01/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.